U3994633G0SC1626Mutagenesis:TMC5_OHu03481C_pcDNA3.1(+ )-Pre-eGFPTarget Insert Name: PrePlasmid…

The University of Virginia has awarded a contract to GenScript USA Inc. effective August 8, 2026, for the provision of molecular biology services and plasmid DNA products. The contract is valued at $178.00 and is designated as A207_PO-0118926-V3. The contracting organization is located in Virginia.

The scope of work encompasses mutagenesis services and delivery of two engineered plasmid constructs: TMC5_OHu03481C_pcDNA3.1(+)-TEV-eGFP and TMC4_OHu10819C_pcDNA3.1(+)-TEV-eGFP. GenScript USA Inc. is required to deliver 178 units of these plasmids in freeze-dried format at a unit price of $1.00 each. Each plasmid delivery includes four micrograms of product free of charge (or one microgram for low-copy plasmids) and specifies distinct cloning sites for each construct: PasI/ApaI for the TMC5 variant and XbaI/XmaJI for the TMC4 variant. Delivery is to be made to the designated buyer at the University of Virginia.